Updated Jul 16, 2026
Olson Tiffany has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Tiffany Olson is listed as a director for Castle Biosciences, Inc. in the SEC filing context dated May 27, 2026. Publicly available SEC documentation in this context only confirms her role as a non-executive director at Castle Biosciences and does not provide additional background such as education or career history beyond the director position.
| Role | Director |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | MDXG | MIMEDX GROUP, INC. | A — Grant or award | 50.9K | $3.64 | $185K |
| 2026-05-27 | CSTL | CASTLE BIOSCIENCES INC | M — Option exercise | 13.7K | — |
Tiffany Olson is listed as a director for Castle Biosciences, Inc. in the SEC filing context dated May 27, 2026. Publicly available SEC documentation in this context only confirms her role as a non-executive director at Castle Biosciences and does not provide additional background such as education or career history beyond the director position.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Olson Tiffany profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.